Prescribed List (Jersey): Changes with effect from 1 February and 1 May 2012

Information about the publication of Ministerial Decisions

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision
providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made on 30 December 2011:

Decision Reference: MD-S-2011-0105
Decision Summary Title :	Prescribed List (Jersey) 1 February 2012 and 1 May 2012		Date of Decision Summary:	27 December 2011
Decision Summary Author:	Policy and Strategy Director		Decision Summary: Public or Exempt?	Public
Type of Report: Oral or Written?	Written		Person Giving Oral Report:	N/A
Written Report Title :	Changes to be made to the Prescribed List (Jersey) as at 1 February 2012 and 1 May 2012		Date of Written Report:	27 December 2011
Written Report Author:	Prescribing Adviser		Written Report : Public or Exempt?	Public
Subject: Changes to be made to the Prescribed List (Jersey) as at 1 February 2012 and 1 May 2012
Decision(s): Items to be included on prescribed list from 1 February 2012 as green items: Prontoderm foam, nasal gel, mouthwash; Prontoderm packs (1 & 2); Chlorhexidine oral spray Glycopyrronium bromide 200 micrograms/mL - 1mL, 3mL amps (generic only) Oxycodone hydrochloride injection 10 mg/mL – 1mL, 2mL amp; 50mg/mL – 1mL amp (open order, Oxynorm) Clonazepam injection 1 mg/mL (open order, Rivotril) BioXtra oral gel – 40mL tube, 50mL spray (brand only) Estradiol 10 micrograms vaginal tablets (open order, Vagifem) Metformin oral powder 500 mg/sachet, 1 g/sachet (open order, Glucophage) Venlafaxine m/r tablets 75mg, 150mg (generic only) Helicobacter test INFAI (brand only) Ibuprofen gel 5%, 10% (open order) Items to be removed from the Prescribed List with effect from 1 May 2012 Mupirocin nasal ointment
Reason(s) for Decision: The Pharmaceutical Benefit Advisory Committee met on 16 November 2011 and recommended changes to the Prescribed List (Jersey). The changes reflect current evidence and expert advice, and ensure that patients in Jersey have access to an appropriate range of modern, safe and effective treatments from their GPs.
Resource Implications: The recommended changes represent an estimated saving to the fund of approximately £55,000 per annum.
Action required: Business Manager to issue a public notice listing amendments and notify all approved medical practitioners and approved contractors.
Signature:		Position: Minister
Date Signed:		Date of Decision (If different from Date Signed):